![Tord Labuda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tord Labuda
Director Ejecutivo en
ALZINOVA AB
.
Perfil
Tord Labuda is Chief Executive Officer at Alzinova AB since 2024.
Formerly, Dr. Labuda was Independent Director at NanoEcho AB from 2023 to 2026 and Vice President & Global Head-Clinical Development at LEO Pharma A from 2008 to 2023.
Education includes a doctorate from the University of Lund.
Cargos activos de Tord Labuda
| Empresas | Cargo | Inicio |
|---|---|---|
| ALZINOVA AB | Director Ejecutivo | 01/10/2024 |
Antiguos cargos conocidos de Tord Labuda.
| Empresas | Cargo | Fin |
|---|---|---|
| NANOECHO AB | Director/Miembro de la Junta | 28/05/2026 |
LEO Pharma A/S
 LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Corporate Officer/Principal | 01/01/2023 |
Formación de Tord Labuda.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
57
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
LEO Pharma A/S
LEO Pharma A/S Medical/Nursing ServicesHealth Services Provides dermatology services | Health Services |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alzinova AB
 Alzinova AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides treatment for Alzheimer’s disease | Health Technology |
Nanoecho AB
 Nanoecho AB Medical SpecialtiesHealth Technology Develops medical ultrasound imaging equipment to treat rectal cancer | Health Technology |
- Bolsa de valores
- Insiders
- Tord Labuda
